wuxi apptec
WuXi STA & Regulus To Collaborate On MicroRNA-Targeting Drugs
The partnership is aimed at accelerating Regulus’ oligonucleotide therapeutics programs into the clinic for the treatment of a variety of diseases.
WuXi AppTec & Mayo Clinic To Jointly Develop Diagnostics
The collaboration will focus on co-developing new diagnostic tests and offering existing ones to health care providers and patients in China.
WuXi Acquires Biologics CRO HD Biosciences
WuXi AppTec strengthens its biologics capabilities with its acquisition of Shanghai-based HD Biosciences.
WuXi Biologics, Prima BioMed To Partner On Manufacturing Cancer Drugs
Under the new agreement, WuXi Biologics will be the exclusive clinical manufacturer of Prima's cancer drugs worldwide.
WuXi AppTec Receives Company Of The Year Award From BayHelix
The award is part of the BayHelix China Healthcare Awards series, which celebrates achievements and contributions to the China healthcare ecosystem.
WuXi AppTec Opens Biomanufacturing Center In Philadeplhia
Pharmaceutical, biotechnology and medical device technology platform company WuXi AppTec has expanded their manufacturing presence in the US.
WuXi Biologics Opens New Manufacturing Facility In China
WuXi Biologics has launched a commercial-scale biologics perfusion manufacturing facility in Wuxi City, China.
WuXi AppTec To Distribute AutoGenomics Diagnostics Systems In China
WuXi AppTec has entered into a distributor agreement with US-based AutoGenomics, focusing on the China market.
WuXi AppTec & Juno Therapeutics Set Up Cell Therapy Company
US-based biopharmaceutical Juno Therapeutics and China-based open-access R&D company, WuXi AppTec, have joined forces in setting up a cell therapy company.
